Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment August 15, 2024October 29, 2024 Ajit Muley
Immunotherapy research is bringing new hope to patients with rare cancers July 22, 2022October 29, 2024 Arthur N. Brodsky, PhD
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma June 28, 2024October 29, 2024 Ajit Muley